Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 58, Issue 4, 1996, Pages 395-401

  James, Sharon Y ^a   Mackay, Alan G ^a   Colston, Kay W ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CLUSTERIN; DNA FRAGMENT; LEXACALCITOL; MESSENGER RNA; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; SEOCALCITOL; VITAMIN D DERIVATIVE;

ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CALCIUM BLOOD LEVEL; CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; TUMOR GROWTH;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0030199843     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)00048-9     Document Type: Article

References (38)

1. 1. Colston K., Chander S. K., Mackay A. G. and Coombes R. C.: Effects of synthetic vitamin D analogs on breast cancer cell proliferation in vivo and in vitro. Biochem. Pharmacol. 44 (1992) 693-702.
2. 3 receptor in breast cancer. Cancer Res. 47 (1987) 6793-6799.
3. 3 receptor content during pregnancy and lactation. Molec. Cell Endocr. 60 (1988) 15-22.
4. 3 receptor in primary breast cancers. Cancer Res. 46 (1986) 5406-5408.
5. 3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology 129 (1991) 832-837.
6. 6. Colston K. W., Mackay A. G., James S. Y., Binderup L., Chander S. and Coombes R. C.: EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem. Pharmacol. 44 (1992) 2273-2280.
7. 7. Wyllie A. H.: Apoptosis: cell death in tissue regulation. J. Pathol. 153 (1987) 313-316.
8. 8. Williams G. T.: Programmed cell death: apoptosis and oncogenesis. Cell 65 (1991) 1097-1098.
9. 9. Arends M. J., Morris R. G. and Wyllie A. H.: Apoptosis: the role of the endonuclease. Am. J. Pathol. 136 (1990) 593-608.
10. 10. Yonish-Rouach F., Rensmitzki D., Lotem J., Sachs L., Kimchi A. and Oren M.: Wild type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin 6. Nature 352 (1991) 345-347.
11. 11. Shaw P., Bovey R., Tardy S., Sahli R., Sordat B. and Costa J.: Induction of apoptosis by wild type p53 in a human colon tumour derived cell line. Proc. Natn. Acad. Sci. U.S.A. 89 (1992) 4495-4499.
12. 12. Barak Y., Juven T., Haffner R. and Oren M.: mdm2 expression is induced by wild-type p53 activity. EMBO J. 12 (1993) 461-468.
13. 13. El-Diery W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W. and Vogelstein B.: WAF1, a potential mediator of p53 tumour suppression. Cell 75 (1993) 817-825.
14. 1 arrest and apoptosis. Cancer Res. 54 (1994) 1169-1174.
15. 1 cyclin dependent kinases. Cell 75 (1993) 805-816.
16. 16. Almeri E. S., Fernandez T. F., Halder S., Croce C. M. and Litwack G.: Involvement of bcl-2 in glucocorticoid-induced apoptosis of human pre-B leukaemias. Cancer Res. 52 (1992) 491-495.
17. 17. Sentman C. L., Shutter J. R., Hockenbery D., Kanagawa O. and Korsmeyer S. J.: Bcl-2 inhibits multiple forms of apoptosis but not negative selections in thymocytes. Cell 67 (1991) 879-898.
18. 18. Kyprianou N., English H., Davidson N. and Isaacs J.: Programmed cell death during regression of the MCF-7 human breast cancer following endocrine ablation. Cancer Res. 51 (1991) 162-166.
19. 19. Warri A. M., Houvinen R. L., Laine A. M., Martikainen P. M. and Harkonen P. L.: Apoptosis in toremifene-induced growth of human breast cancer cells in vivo and in vitro. J. Natl. Cancer lnst. 85 (1993) 1412-1418.
20. 20. Wong P., Taillefer D., Lakins J., Pineault J., Chader G. and Tenniswood M.: Molecular characterisation of human TRPM-2/clusterin, a gene associated with sperm maturation, apoptosis and neurodegeneration. Eur. J. Biochem. 221 (1994) 917-925.
21. 21. Binderup L. and Bramm E.: Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem. Pharmacol. 37 (1988) 889-895.
22. 22. Mathiasen I. S., Colston K. W. and Binderup L.: EB1089, a novel vitamin D analogue, has strong anti-proliferative and differentiation inducing effects on cancer cells. J. Steroid Biochem. Molec. Biol. 46 (1993) 365-371.
23. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem. Pharmacol. 42 (1991) 1569-1575.
24. 24. Bradford M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein dye binding. Analyt. Biochem. 72 (1976) 248-254.
25. 3: co-ordinate regulator of active cell death and proliferation in MCF-7 breast cancer cells. In: Ernst Schering Foundation Workshop, Vol. 14: Apoptosis in Hormone Dependent Cancers. (Edited by M. Tenniswood and H. Michna). Springer Verlag, Berlin, (1995) pp. 181-200.
26. 26. Oberhammer F., Wilson J. W., Dive C., Morris I. D., Hickman J. A., Wakeling A. E., Walker P. R. and Sikorska M.: Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kB fragments prior to or in the absence of internucleosomal degradation. EMBO J. 12 (1993) 3679-3684.
27. 27. Pandey S., Walker P. R. and Sikorska M.: Separate pools of endonuclease activity are responsible for internucleosomal and high molecular mass DNA fragmentation during apoptosis. Biochem. Cell Biol. 72 (1994) 625-629.
28. 28. Schmitz G., Walter T., Seibl R. and Kessler C.: Non radioactive labelling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Analyt. Biochem. 192 (1991) 222-231.
29. 29. Tenniswood M., Guenette R. S., Lakins J., Mooibroek M., Wong P. and Welsh J. E.: Active cell death in hormone dependent tissues. Cancer Metast. Rev. 11 (1992) 197-220.
30. 30. Montpetit M. L., Lawless K. R. and Tenniswood M.: Androgen-repressed messages in the rat ventral prostate. Prostate 8 (1986) 25-36.
31. 31. Merlo G. R., Basolo F., Fiore L., Duboc L. and Hynes N. E.: p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. J. Cell Biol. 128 (1995) 1185-1196.
32. 32. Lotem J. and Sachs L.: Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemia cells. Cell Growth Diff. 4 (1993) 41-47.
33. 33. Moll U. M., Rion G. and Levine A. J.: Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. Natn. Acad. Sci. U.S.A. 89 (1992) 7262-7266.
34. 34. Tsujimoto Y., Finger L., Yunis J., Nowell P. C. and Croce C. M.: Cloning of the chromosome breakpoint of neoplastic B cells with the t(14:18) chromosome translocation. Science 226 (1984) 1097-1099.
35. 35. Negrini M., Sabbioni S., Halder S., Possati L., Castagnoli A., Corallini A., Barbanti-Brodano G. and Croce C. M.: Tumour and growth suppression of breast cancer cells by chromosome 17 associated functions. Cancer Res. 54 (1994) 1818-1824.
36. 3 in MCF-7 breast cancer cells. In Vitamin D - A Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications (Edited by A.W. Norman, R. Bouillon and M. Thomasset). Walter de Gruyter, Berlin (1994) pp. 526-527.
37. CIP/Waf1 expression in human breast epithelial cells. Oncogene 11 (1995) 253-261.
38. 3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res. 55 (1995) 2822-2830.